Erin Lavelle serves as Executive at ALDER BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Erin Lavelle has executed 4 insider transactions totaling $19.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 22, 2019 involved transacting 16,092 shares valued at $289.7K.
Erin Lavelle currently holds 16,092 shares of ALDER BIOPHARMACEUTICALS INC (ALDR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erin Lavelle has been a net seller of ALDR stock. They have purchased $0 and sold $19.6K worth of shares.
Erin Lavelle's most recent insider trade was on Oct 22, 2019, when they sold 16,092 shares at $18.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 25, 2019 | ALDR | $19.6K | Sale | 1,434 | $13.67 | Discretionary |
| Apr 23, 2019 | ALDR | $0 | Award | 5,842 | $N/A | Discretionary |